System (100) comprising a device (101) comprising a body (102), an ion conductive member (120), a first electrode (131), and a second electrode (132). The system (100) further comprises a source solution (141), a target solution (142), a first species (151), and a second species (152). A first end (121) of the ion conductive member (120) is arranged in contact with 5 the source solution (141). A second end (122) of the ion conductive member (120) is arranged in contact with the target solution (142). The first electrode (131) is arranged in contact with the source solution (141), the second electrode (132) is arranged in contact with the target solution (142), the first species (151) is in the source solution (141), and the second species (152) is in the target solution (142). Under the influence of an electrical field, the first species (151) is 10 transported through the ion conductive member (120) from the source solution (141) to the target solution (142) and interacts with the second species (152), such that at least one part (153) of the second species (152) is released.

Apparatus is provided that includes a two-dimensional arrangement (70) of extracranial electrodes (30), configured to be placed outside and in electrical contact with a skull of a subject identified as at risk of or suffering from a disease; and a cerebrospinal fluid (CSF) electrode (32), configured to be implanted in a ventricular system of a brain of the subject. Control circuitry is configured to drive the extracranial and the CSF electrodes (30, 32) to clear a substance from brain parenchyma of the subject into at least one region of the brain selected from the group consisting of: a subarachnoid space of the brain and dural sinuses of the brain. Other embodiments are also described.

The present invention relates to an electrochemical device for releasing ions, comprising an electrical circuit comprising a first electrode and a second electrode adapted for providing a galvanic cell when the electrodes are exposed to a fluid constituting an electrolyte, and a boost converter adapted for amplifying a potential generated between the first and the second electrode. The electrical circuit further comprises a third electrode connected with an output side of the boost converter, wherein the second and the third electrode constitutes an electrolytic cell powered by the galvanic cell when the electrodes are exposed to a fluid. The present invention further relates to devices, such as a toothbrush or a shaver, adapted for being used in connection with a fluid, comprising such electrochemical device for releasing ions.

An oral care device (8) for use in aiding delivery of a substance for an oral treatment purpose within the mouth. The device comprises a field generator (16) which is adapted to generate a field (20) for exerting a force on particles (20) susceptible to the field to guide movement of the particles to a desired location. When operated in the mouth, this allows oral treatment particles to be quickly, safely and efficiently distributed within the mouth to the correct locations for performing the oral treatment function.

An implantable neural tissue electrode assembly includes a cylindrical electrode lead with at least one electrode contact on the outer surface of the electrode lead. An active distal end fixation anchor is located at the distal end of the electrode lead and is adapted to fasten to adjacent tissue by rotation in a fastening direction. A passive rear fixation anchor is located on the outer surface of the electrode lead offset a longitudinal distance back from the distal end and has at least one curved blade with a blade tip directed away from rotation in the fastening direction. The rear fixation anchor is adapted to permanently fasten to adjacent tissue by rotation opposite to the fastening direction so that the blade tip cuts into the adjacent tissue, and the electrode assembly is adapted such that physiological induced strains are distributed along the electrode lead.

A skin treatment device is provided, which includes a needle frame in which a front end outlet of a needle that penetrates an inside thereof projects toward a front thereof, a rear end inlet of the needle is open to an outside of a rear surface thereof, and a stepped partition wall is provided in a closed shape on the outside of the rear surface thereof; a needle cover having a space portion formed on a rear thereof toward an inside thereof, a needle guide portion formed on a front surface thereof; a contact PCB configured to receive a power that is supplied from a power supply device; and a needle hub having an insertion portion formed in a front thereof toward an inside thereof.

A method for delivery of oral iontophoretic or reverse-iontophoretic effect by electrical current in combination with electrokinetic elements (e.g., ions, charged molecule(s) (such as a medication or a bioactive agent), and/or charged molecular complexes that may include uncharged molecules), the electrical current causing a motive force on such elements to and from biological tissues and fluids.

The present disclosure relates to a medicament delivery device comprising at least one microneedle for delivering a medicament to a patient, and a system configured to enhance the penetration of the medicament into skin of the patient.

A method for treating an intervertebral disc of a subject is provided, the method including delivering a growth factor to a nucleus pulposus of the intervertebral disc. At least one intra-pulposus exposed electrode surface is implanted in the nucleus pulposus. At least one extra-pulposus exposed electrode surface is implanted in a body of the subject outside the nucleus pulposus. The growth factor is supported by activating control circuitry to drive the intra-pulposus and the extra-pulposus exposed electrode surfaces to electroosmotically drive nutrient-containing fluid into the nucleus pulposus. Other embodiments are also described.

An apparatus for controlled healing of ocular erosions is described. The apparatus comprising; an optical surface comprising an energizable controller capable of being programmed to transmit energy from an energy source onto/into an ocular surface, through the use of a current generator in electrical connection with energy emitting contacts capable of transmitting an electric field. The controller, current generator and energy emitting contacts are biocompatible or encapsulated by a conductive biocompatible layer to allow positioning of said apparatus in an ocular surface.